dsha

@ShortSeller wrong on both counts! Great earnings, rest of complex up bigly only MU down. wow how are you so bad at this

$MU Observation....INCAREDIBLE earnings....= likely kill the stock *but* be careful this one might be a catalyst to take down the whole complex (would be a gift) $EWY $SNDK $LITE etc..... $KOSPI

@RJCcapital Cope harder maybe

$MU fwd pe down to 5x

@AuditTheHerd thanks for being transparent about exiting higher than the prevailing market price

Portfolio Update — Exiting $PATH Full transparency as I think it is important even if I get hate, I sold my full position in UiPath yesterday. Here’s my thinking: When I built my thesis, the core assumption was that UiPath would accelerate into the agentic AI era. Enterprises were already deeply embedded in their automation workflows, and the logical next step was orchestrating AI agents on top of that foundation — high switching costs, expanding NRR, compounding growth. That was my bet back in October. Not only did the Anthropic news come out after that but growth came in slower than my model had forecasted. Even with solid fundamentals, the MOAT deterioration is impacting pricing power and growth…. this is not a moment to walk to the finish line. In high stakes AI infrastructure, growth is the moat and if that growth doesn’t arrive on schedule, the valuation math starts working against you fast. There is still a credible path for UiPath to grow into the orchestration layer and I think they should easily beat guidance. But the window is narrowing every day, and I can’t say with confidence where they stand in 5–10 years. When the thesis isn’t as strong as you think it was, you exit. Not when the stock is down. Not when sentiment turns. When the underlying assumptions that got you in no longer hold. Proceeds rotated into three positions: $LMND — Perhaps my most predictable position. Lemonade is AI native at its core ….not a legacy insurer “utilizing” technology, but a company built from the ground up around machine learning underwriting. The key metrics I’m watching are loss ratio trajectory and car insurance expansion. As their models improve at pricing risk, margins expand structurally. The trajectory is improving and I’m comfortable sizing up here. $TEM — Tempus AI is building what may become the most valuable proprietary dataset in oncology. They combine large scale genomic sequencing with real world clinical data, then apply AI to surface actionable insights for physicians at the point of care. Data network effects in healthcare are extraordinarily difficult to replicate once you have the data advantage, it compounds. This is my largest position and I’m comfortable holding through further volatility as long as the thesis remains intact. $ODD — I’ve held ODDITY on and off for a long time(since ipo) and I’m not going anywhere. The recent selloff has been a bit overblown imo— the stock dropped nearly 50% after management disclosed a CAC dislocation driven by algorithm changes at their largest advertising partner, which pushed spend into lower quality auctions and more than doubled acquisition costs. Q1 2026 revenue is expected to decline roughly 30% YoY as a result. That’s painful on the surface. But the underlying business health tells me something else: 70% of 2025 revenue came from repeat customers, new brand launches, CEO buying $10m worth of shares and a pristine balance sheet. Management believes they’ve identified the root cause and are targeting normalized CAC by Q3 or Q4. I believe them. This to me reads as a technical pothole, not a structural crack. The brand equity, retention metrics, and ODDITY LABS product pipeline remain intact for me. Current allocation for portfolio: 50% $TEM 30% $LMND 20% $ODD To be clear; these positions have been hit hard and I expect potentially more downside which I am fine with. I don’t think people understand that short term pricing does not mean anything to me. $TEM could go to $30 and as long as the business fundamentals stay in tact, I won’t blink an eye. Do not buy if you’re not ok with volatility. Best of luck to $PATH holders, I can still see potential upside from here. NFA. ~@AuditTheHerd

@FinanceJack44 what’s their FCF this year?

$MSFT is now $390, down 29% from all time highs. If you ask me this is one of the best buys in the market right now. Microsoft is as blue chip as it gets, and the stock price going down doesn't change the fact that the company: - Is growing revenue 16% - Generated $80 billion in FCF last year - Has a $600 billion RPO backlog - Has minimal debt + 95 billion in cash/treasuries At this price you are getting all that at a 24 PE. That's a fantastic risk/reward setup.

@ShortSeller “Been in since 12”

$NKTR Still Sexy

@Gubloinvestor oof

Wife bought $UPST at $33 and it went to $99 in 2025. She did not sell a single share and not planning on doing it either. its been over 18 months since she has this position. Basically if $UPST goes below $20, i will add some leaps and shares both. my price target for $UPST still remains at $150 in 2028.

@ShortSeller EVEN BETTER!!

$AXTI...no, not $10 - been long since Sub 3 -fckface #AnnualizeThis

@hamids Go all In Then

After the absolutely INSANE Q2 beat by $MU, the raise in Q3 guidance and outlook, combined with the market's truly retarded reaction, I had to buy even more Micron! Micron just became the largest investment I have ever made into a single company, surpassing my investment in $RIVN today.

@DividendTalks Are you retarded

Bill Ackman went $2B long $META at $625. Now it’s down ~30%. His view: “Deeply discounted. Huge AI upside.” Market today says he’s wrong. History says don’t bet against him. Who’s right this time?

@ShortSeller “I’ve been in it since $10” LOL

$AXTI 1700% now ...what a beast

@Gubloinvestor Didn’t you sell rbrk at a loss recently

Add $ZETA $RBRK $META $AMZN $SOFI in your portfolio and come back in 2030. You will be far more richer than most of the X users.

@TSinvests_ @trevhesinvests Exactly

@itsdsha @trevhesinvests Slop

No brainer prices to add to these stocks (Pt. 2): 1. $NVDA @ $144.35 2. $MELI @ $1,324.52 3. $NFLX @ $74.78 4. $SHOP @ $96.07 5. $IREN @ $32.75 6. $RKLB @ $49.56 7. $ASTS @ $58.76 8. $HOOD @ $50.19 9. $PLTR @ $80.46 10. $GOOG @ $232.88 Thoughts?

@trevhesinvests what’s the point?

@itsdsha Which do you disagree with?

@investingwithac nice alpha bro

If you thought…. $OSCR was a buy at $20 It’s definitely a buy at $13 $ZETA was a buy at $25 It’s definitely a buy at $17 $IREN was a buy at $70+ It’s definitely a buy at $41 $SOFI was a buy at $29 It’s definitely a buy at $17

@ZephyrVision i guess there!

@itsdsha There's support here. At what price are you prepared to buy?

Bought some $MU This is silly

@__Con_ then do it

@itsdsha I have 5 things rn 1) $GLXY 2) $HOOD 3) $COIN 4) $NIO 5) $ZETA But you can really consolidate the glxy and hood into coin. That's why I only said 3 stocks.

Buy these 3 stocks and hold: 1) $COIN 2) $NIO 3) $ZETA It's as simple as that. That'll outperform 99.9% of hedge funds in 2026.

@andruyeung Enjoy it while it lasts!

My new favorite NYC life hack: take Ubers for ~50% of the price It’s called Empower I took a car from Manhattan to Newark during peak time. It cost $61 (usually >$120) What’s the catch? I looked into it: Drivers pay a monthly subscription fee to be listed on the app. In return empower takes no cut (vs 30% from Uber) Drives set their own prices So legally they are not a ride share biz but a marketplace Founder is a lawyer who interned at the White House. He figured this out! P.s. this is NOT a paid promo. Just had a great experience that is all.

@DimitryNakhla was it an opportunity or a trap? lol

DLocal $DLO Q4 2025 Report ✅ REV: $337.9M (+65% YoY) ✅ EPS: $0.18 (+80%) 💵 Q4 FCF $64.9M (+100% YoY) 💵 2025 FY FCF $191M (+110% YoY) 💰 $DLO holds $424.5M in corporate cash & equivalents 💸 “Board authorized a new share repurchase program to purchase up to $300M”

@PhotonCap yup I sold my lungs and went all in!

$AAOI I made it🫡